A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Clinical trial NCT07391761 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07391761
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-11
- Primary completion
- 2028-01-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.